MEDIUM · 5.4

CVE-2023-40355

Cross Site Scripting (XSS) vulnerability in Axigen versions 10.3.3.0 before 10.3.3.59, 10.4.0 before 10.4.19, and 10.5.0 before 10.5.5, allows authenticated attackers to execute arbitrary code and obt...

Vulnerability Description

Cross Site Scripting (XSS) vulnerability in Axigen versions 10.3.3.0 before 10.3.3.59, 10.4.0 before 10.4.19, and 10.5.0 before 10.5.5, allows authenticated attackers to execute arbitrary code and obtain sensitive information via the logic for switching between the Standard and Ajax versions.

CVSS Score

5.4

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
CHANGED
Confidentiality
LOW
Integrity
LOW
Availability
NONE

Affected Products

VendorProductVersions
AxigenAxigen Mobile Webmail>= 10.3.3.0, < 10.3.3.59

Related Weaknesses (CWE)

References

FAQ

What is CVE-2023-40355?

CVE-2023-40355 is a vulnerability with a CVSS score of 5.4 (MEDIUM). Cross Site Scripting (XSS) vulnerability in Axigen versions 10.3.3.0 before 10.3.3.59, 10.4.0 before 10.4.19, and 10.5.0 before 10.5.5, allows authenticated attackers to execute arbitrary code and obt...

How severe is CVE-2023-40355?

CVE-2023-40355 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-40355?

Check the references section above for vendor advisories and patch information. Affected products include: Axigen Axigen Mobile Webmail.